Published in Gene Therapy Weekly, August 19th, 2004
"Infection of human T lymphocytes with the Herpesvirus saimiri (HVS) yields immortalized T-cell lines (HVS-T) which retain all the phenotypical and functional characteristics of their parental cells. This represents a new experimental model for studying genetic disorders of T lymphocytes.
"In spite of the efforts of many laboratories, no satisfactory way has been found so far to modify HVS-T cells genetically," scientists writing in the journal Gene Therapy report.
"We have analyzed the capacity of oncoretroviral (MLV)- and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.